Table 3.
Implant specific history (n = 140).
| Characteristic | Value | Percentage* |
|---|---|---|
| Duration of silicone exposure, mean ± SD in years (range) | 14.4 ± 7.4 (1–46) | NA |
| Duration of BII symptoms, mean ± SD in years (range) | 6.2 ± 5.5 (0–26) | NA |
| Time to onset of symptoms, mean ± SD in years (range) | 7.0 ± 7.4 (0–30) | NA |
| Reimplantation | 41 | 29.3% |
| Once | 32 | 22.9% |
| Multiple | 9 | 6.4% |
| Implant size, mean ± SD in cc’s (range)† | 300.6 ± 76.1 (150–570) | NA |
| Reason for implantation | ||
| Cosmetic | 137 | 97.9% |
| Reconstructive | 3 | 2.1% |
| Implant type | ||
| Silicone | 134 | 95.7% |
| Saline | 6 | 4.3% |
| Implant brand | Allergan (31.8%), Mentor (16.2%), Eurosilicone (14.9%) | |
*Percentage over total SBI population (n = 140). NA = Not applicable. † 12 missing values.